New human tissue chips aim to replace animal testing

New human tissue chips aim to replace animal testing

Animal testing has long been the standard for evaluating new drugs before they reach human patients. But when it comes to cancer immunotherapy drugs, animal models often fail to predict which immunotherapies might produce harmful side effects in humans because they do not have the same responses or the same cell receptors.

CN Bio awarded Innovate UK grant to reduce animal use

CN Bio, a provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, has announced it has been awarded £180k grant funding from Innovate UK.

CN Bio awarded Innovate UK grant to reduce animal use in pharmacokinetic studies

CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, today announced it has been awarded £180k grant funding from Innovate UK. Grant funding delivered in partnership with the NC3Rs, in support of UK Government roadmap to reduce animal testing by 2030 Project to develop standardized workflow to more accurately predict drug behaviors, reduce animal testing and streamli…

US FDA Aims to Reduce Animal Testing to Modernize Drug Development

The post US FDA Aims to Reduce Animal Testing to Modernize Drug Development appeared first on TechAcute. If this article has been copied anywhere else without permission it will be subject to legal action.